ARROWHEAD PHARMACEUTICALS, INC. financial data

Symbol
ARWR on Nasdaq
Location
Pasadena, CA
Fiscal year end
30 September
Latest financial report
10-Q - Q4 2025 - 05 Feb 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 439% % -30%
Return On Equity 36% %
Return On Assets 14% %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 140,032,190 shares 11%
Common Stock, Shares, Outstanding 137,391,000 shares 9.4%
Entity Public Float $1,400,000,000 USD -53%
Common Stock, Value, Issued $233,000 USD 6.9%
Weighted Average Number of Shares Outstanding, Basic 137,039,000 shares 9.8%
Weighted Average Number of Shares Outstanding, Diluted 140,706,000 shares 13%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $1,090,981,000 USD 43539%
Research and Development Expense $177,203,000 USD 29%
General and Administrative Expense $143,054,000 USD 40%
Operating Income (Loss) $300,567,000 USD
Nonoperating Income (Expense) $45,648,000 USD -99%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $254,919,000 USD
Income Tax Expense (Benefit) $29,000 USD -72%
Net Income (Loss) Attributable to Parent $202,265,000 USD
Earnings Per Share, Basic 1.6 USD/shares
Earnings Per Share, Diluted 1.6 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $69,400,000 USD -34%
Accounts Receivable, after Allowance for Credit Loss, Current $218,871,000 USD 8655%
Other Assets, Current $22,855,000 USD 299%
Assets, Current $1,174,389,000 USD 106%
Property, Plant and Equipment, Net $378,584,000 USD -2.2%
Operating Lease, Right-of-Use Asset $43,361,000 USD -3.4%
Other Assets, Noncurrent $1,411,000 USD -54%
Assets $1,604,181,000 USD 58%
Accounts Payable, Current $32,937,000 USD 128%
Employee-related Liabilities, Current $14,270,000 USD 27%
Accrued Liabilities, Current $130,081,000 USD 119%
Contract with Customer, Liability, Current $111,933,000 USD
Liabilities, Current $347,425,000 USD 271%
Contract with Customer, Liability, Noncurrent $53,825,000 USD
Operating Lease, Liability, Noncurrent $102,129,000 USD -6.6%
Accumulated Other Comprehensive Income (Loss), Net of Tax $6,699,000 USD 62%
Retained Earnings (Accumulated Deficit) $1,596,343,000 USD 11%
Stockholders' Equity Attributable to Parent $568,422,000 USD 981%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $562,697,000 USD 903%
Liabilities and Equity $1,604,181,000 USD 58%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $13,481,000 USD
Net Cash Provided by (Used in) Financing Activities $14,750,000 USD -171%
Net Cash Provided by (Used in) Investing Activities $23,742,000 USD -131%
Common Stock, Shares Authorized 290,000,000 shares 0%
Common Stock, Shares, Issued 140,052,000 shares 12%
Common Stock, Par or Stated Value Per Share 0.001 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $201,643,000 USD 274%
Deferred Tax Assets, Valuation Allowance $497,543,000 USD 11%
Deferred Tax Assets, Gross $562,686,000 USD 19%
Operating Lease, Liability $109,658,000 USD -5.4%
Payments to Acquire Property, Plant, and Equipment $2,148,000 USD -71%
Lessee, Operating Lease, Liability, to be Paid $169,614,000 USD -8.2%
Property, Plant and Equipment, Gross $464,733,000 USD 3.3%
Operating Lease, Liability, Current $7,529,000 USD 15%
Lessee, Operating Lease, Liability, to be Paid, Year Two $13,696,000 USD -8.5%
Lessee, Operating Lease, Liability, to be Paid, Year One $15,050,000 USD -4.7%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $59,956,000 USD -13%
Lessee, Operating Lease, Liability, to be Paid, Year Three $13,985,000 USD 2.7%
Deferred Tax Assets, Operating Loss Carryforwards $70,858,000 USD -31%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5,000,000 shares 0%
Unrecognized Tax Benefits $22,152,000 USD 33%
Lessee, Operating Lease, Liability, to be Paid, Year Four $14,282,000 USD 2.7%
Operating Lease, Payments $15,577,000 USD 22%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets $1,700,000 USD 0%
Depreciation, Depletion and Amortization $23,400,000 USD 31%
Share-based Payment Arrangement, Expense $60,263,000 USD -5.2%
Interest Expense $23,031,000 USD 43%
Preferred Stock, Par or Stated Value Per Share 0.001 USD/shares 0%